Top login menu

Murray Edwards College
University of Cambridge
  • Home
  • Main page content

    Dr Charlie Bell

    Murray Edwards College
    CB3 0DF

    Post-doctoral Bye Fellow in Medicine


    Bye fellow

    Murray Edwards is an extraordinary place, because it offers so much to its students (and Fellows) in so many different areas. Whether it’s preparing them for work and study with Gateway, sporting or cultural pursuits, or simply allowing members of the college to interact academically and socially, its ambition and its opportunities are second to none.

    Degrees and honours

    MA (Cantab 2015)

    PhD (Cantab 2015)

    MAcadMEd (2014)

    MRSB (2014)

    Awards and prizes

    Munro Scholar, Queens’ College, Cambridge (2015-6)

    College Prize for Academic Excellence, Ryell and Bibby Prize, Queens’ College, Cambridge (2010)


    Charlie Bell came up to Cambridge in 2008 to read medical sciences at Queens’ College as part of the MB PhD programme. He undertook a PhD investigating the mechanisms responsible for the development of type 1 diabetes with Professor John Todd in the Cambridge Institute for Medical Research, with involvement in clinical trials and driving in vivo and in vitro laboratory studies. It was during this time that he found a passion for supervising undergraduate medics and natural scientists. He has been doing so since then, in subjects ranging from reproductive physiology to biochemistry. He is currently completing his medical degree and plans to pursue an academic medical career in oncology, and was recently an Exchange Scholar at Mt Sinai Hospital, in New York City, characterizing the role of the immune system in melanoma. Outside of Cambridge, he chairs the national Medical Student Committee for the British Medical Association.


    Charles J.M. Bell, (2013) "Public health implications of spiritual healing practice, in conditions such as depression", Journal of Public Mental Health, Vol. 12 Iss: 1, pp.6 – 9

    Charles J.M. Bell et al, (2014) “Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells”, Journal of Autoimmunity, ePub ahead of print, October 2014

    Charles J.M. Bell et al (in preparation) “Interleukin-2 activated CD56bright NK cells show an immunoregulatory phenotype”

    Todd, J. A., Evangelou, M., Cutler, A. J., Pekalski, M. L., Walker, N. M., Stevens, H. E., Porter, L., Smyth, D. J., Rainbow, D. B., Ferreira, R. C., Esposito, L., Hunter, K. M. D., Loudon, K., Irons, K., Yang, J. H., Bell, C. J. M., Schuilenburg, H., Heywood, J., Challis, B., Neupane, S., Clarke, P., Coleman, G., Dawson, S., Goymer, D., Anselmiova, K., Kennet, J., Brown, J., Caddy, S. L., Lu, J., Greatorex, J., Goodfellow, I., Wallace, C., Tree, T. I., Evans, M., Mander, A. P., Bond, S., Wicker, L. S., Waldron-Lynch, F., (2016) “Regulatory T Cell Responses in Participants with Type 1 1 Diabetes after a Single-Dose of Interleukin-2: A Non-Randomized, Open Label, Adaptive Dose-Finding Trial”, PLoS Medicine, online version 11th October